hsp 90 inhibitors and the treatment of lung cancer
Published 10 years ago • 246 plays • Length 2:18Download video MP4
Download video MP3
Similar videos
-
19:48
hsp-90 inhibition and other potential targets in the management of nsclc
-
0:32
dr. reckamp discusses the use of hsp90 inhibitors
-
1:06
dr. suresh ramalingam on hsp90 inhibition with ganetespib in lung cancer
-
2:00
dr. ramalingam discusses hsp90 as treatment for lung cancer
-
2:17
hsp 90 inhibitors & may they help fight lung cancer?
-
2:53
dr. suresh ramalingam on hsp90 inhibition with ganetespib
-
4:56
galaxy-1 trial: investigation of hsp90 inhibitors in nsclc
-
31:25
immunotherapy updates unlocked: an interactive digital engagement showcase
-
8:14
phase ii study of the hsp90 inhibitor ganetespib as monotherapy in patients with advanced nsclc
-
0:59
is adc the answer to lung cancer #2023 #oncology #lungcancer
-
51:41
september 10, 2022, revolution cancer international molecular tumor board- hutchmed, alk, met, hsp90
-
12:33
introduction: checkpoint inhibition in non-small cell lung cancer
-
4:18
using hsp90 inhibitors in the clinic: what have we learned?
-
28:17
segment 1: egfr tkis in nsclc
-
30:32
2023 best of lung: targeted therapies in lung cancer
-
5:59
asco 2013: ganetespib inhibits hsp90 with docetaxel for advanced lung cancer
-
4:36
efficacy and safety of checkpoint inhibitors in lung cancer
-
17:30
immunotherapy in lung cancer: panacea vs. reality?
-
18:41
extreme rare mutations in lung cancer (ros1, trk, her2): treatment opportunities